About
Jon joined Horizon Discovery to lead its oncology target validation and drug discovery efforts. Prior to this, he enjoyed 10 years at Vernalis culminating in a role as Head of Biology, where he was responsible for both cell biology and assay development activities. He also led the biology side of several innovative drug discovery programs and managed a major research alliance with GSK. Jon’s research interests include cancer metabolism, signal transduction and, prior to making the move to industry, he gained extensive postdoctoral experience in the cell cycle control field working with first Sally Kornbluth at Duke and then Nobel Prize winner, Tim Hunt, at Cancer Research UK’s Clare Hall labs. He holds a PhD from the University of Newcastle upon Tyne and is a Fellow of the Society of Biology.
Investment Focus
- Location
- Cambridge, US
Contact Information
Find more investors like Jon
Search Investors